Appyea Inc (QB) (APYP) News

$APYP A new app for iOS and Android with upgraded algorithms and additional functions and a new design will soon be available in Google and Apple stores. Be ready, we will update soon.

$APYP
A new app for iOS and Android with upgraded algorithms and additional functions and a new design will soon be available in Google and Apple stores. Be ready, we will update soon. pic.twitter.com/AziNeUDXBJ— AppySleep (OTCQB: APYP) (@SleepXclear) June 4, 2024

Looks like both the company store and the store on Amazon are all out of Appysleep. Sold out. Time to reorder.

Keep an eye on when it's restocked. That should be a good indicator when the Apple version is being released.

$APYP A new app for iOS and Android with upgraded algorithms and additional functions and a new design will soon be available in Google and Apple stores. Be ready, we will update soon.

$APYP
A new app for iOS and Android with upgraded algorithms and additional functions and a new design will soon be available in Google and Apple stores. Be ready, we will update soon. pic.twitter.com/AziNeUDXBJ— AppySleep (OTCQB: APYP) (@SleepXclear) June 4, 2024

They sell through Amazon as well as their own website. They have more they one place to sell online.

So what about it ! Still unavailable. 0 sales = 0 $$$

https://www.amazon.com/dp/B0CTMNHQBX?ref=myi_title_dp

AppySleep Anti Snoring Smart Wristband Watch with Patented Snore Sensing Technology & Smartphone Android App, Sleep Pattern Monitor Device, Soluciones para Los Ronquidos para Mujeres y Hombres

Looks like hefty sales cleared them out. Reordering should be easy now that the product is on the market.

Amazon ad says " currently unavailable ". Can't make a dime when that is the status !

Form 10-Q has been filed.

Sales must be good.

Amazon link https://www.amazon.com/AppySleep-Wristband-Technology-Smartphone-Soluciones/dp/B0CTMNHQBX

$APYP NEW YORK, NY / ACCESSWIRE / May 16, 2024 / AppYea Inc. (OTCQB:APYP), developer of an innovative wearable monitoring solution to monitor and treat sleep apnea and snoring, today announced the conversion of the majority of debt owed to its Chairman, Boris (Bary) Molchadsky, who converted approximately $140,000 of debt into AppYea warrants with a strike price of $0.07 per share, reflecting a premium of more than 250% over the current market price of the Company's common shares.

AppYea recently entered its commercial phase with the first deliveries of AppySleep to customers in the United States. Additionally, the Company has launched a new direct sales website, AppySleep.com, and a new e-commerce store on Amazon.



Mr. Molchadsky commented on the conversion, stating, "This conversion demonstrates my utmost confidence in the prospects and business, given the fact I am converting debt into warrants with a strike price set at a substantial premium to the current market price. The Company has made tremendous progress and I do not believe the current market price of the Company's common stock reflects the intrinsic value of our business or robust intellectual property. In particular, after years of development, we have started delivering our first product, AppySleep. There is increasing consumer awareness about the significance of healthy sleep, and our goal is to diagnose and alleviate a variety of major sleep disorders."

AppYea's commitment to innovation and user-centric design marks a new era in sleep wellness. AppySleep is a compact, lightweight, and comfortable smart wristband designed for use during sleep. This wristband seamlessly incorporates multiple sensors and interfaces with the AppySleep smartphone app via Bluetooth. The app, utilizing the smartphone's microphone, actively monitors breathing patterns during sleep. When it detects several consecutive snores, the wristband responds with a gentle vibration, prompting the user to adjust their sleeping position and naturally cease snoring. The key to AppySleep's effectiveness lies in its user-friendly design and gradual training approach. Over continuous use spanning several weeks, users typically acclimate to sleeping in a correct and healthy position, significantly reducing, or eliminating snoring.



About AppYea

AppYea is a Healthtech company commercializing innovative wearable technology for the treatment of snoring and developing wearable solutions to diagnose and treat sleep apnea. The Company's solutions are based on its proprietary IP portfolio of AI and sensing technologies for the tracking and analysis of breathing patterns, vital signs, and other physiological parameters during sleep, designed for greater accuracy at lower and affordable cost. For more information on AppYea please go to Appyea.com.

Cautionary Note Regarding Forward-Looking Statements

Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of AppYea are subject to many factors including, but not limited to, the sufficiency or working capital and our ability to raise the capital needed to fund our development efforts, the going concern qualification in our financials, timing of product development, customer acceptance of our products in the market, the introduction of competitive products, the effectiveness of our product distribution networks, the impact of any product liability or other adverse litigation, commercialization and technological difficulties, and the other risks identified in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission on April 1, 2024. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information, or otherwise.

Contact:

Crescendo Communications, LLC
Tel: (212) 671-1020
Email: APYP@Crescendo-IR.com

SOURCE: APPYEA, Inc.



https://www.pharmiweb.com/press-release/2024-05-16/appyea-chairman-bary-molchadsky-demonstrates-confidence-by-converting-debt-to-warrants-with-a-strike

The wristband is done. Only need to do software updates from time to time. I don't see how the war effects APYP. Maybe a little, but not the end of the world.

Yeah that's what they want you to think

Israel’s tech sector shows resilience despite challenges post-Oct. 7



https://www.jns.org/israels-tech-sector-shows-resilience-despite-challenges-post-oct-7/

https://en.mehrnews.com/news/213766/Samsung-Next-pulls-out-of-Israeli-tech-industry

Samsung Next closes office in Tel Aviv, Israel due to oppression against Palestinian people. All (tech) companies in Israel will face a major demise.

https://www.tiktok.com/@pauliezofficial/video/7348945518258621739

https://www.facebook.com/pauliezofficial/

Sorry I meant to say GO $APYP

A big step in the right direction. Go $BRLL

$APYP AppYea Launches E-Commerce Store on Amazon Broadening Distribution

https://www.accesswire.com/844979/appyea-launches-e-commerce-store-on-amazon-broadening-distribution

$APYP trending up I see. Getting ready to breakout and run?

🔳🔳Success is *COMING* to APYP: FALCONISHNESS to the extreme?:

*** FALCONISHNESS to the EXTREME? ***

********************
*** I like it a lot? ***
********************

What are your thoughts about this?

$APYP Form 424B3 - Prospectus [Rule 424(b)(3)]

https://ih.advfn.com/stock-market/USOTC/appyea-qb-APYP/stock-news/93359119/form-424b3-prospectus-rule-424b3

https://ca.linkedin.com/in/alan-kline-93925b36

$APYP



https://www.instagram.com/p/C3GjyLku3Ng/

https://www.facebook.com/pauliezofficial/

https://www.instagram.com/p/C3i7F4APbCV/?igsh=YmM1ZTV2MGVobWYz

Was hoping to get some in the 2cent range, holding 3cent nicely

$APYP Global Anti-Snoring Devices Market Analysis: 2023 Forecast

Publish Date:February 2024

The global anti-snoring devices market is expected to grow from $1.53 billion in 2022 to $1.67 billion in 2023 at a compound annual growth rate (CAGR) of 9.3%.

North America was the largest region in the anti-snoring devices market in 2022.Asia-Pacific is expected to be the fastest-growing region in the forecast period.

The regions covered in the anti-snoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

https://www.reportlinker.com/p06486522/Anti-Snoring-Devices-Global-Market-Report.html?utm_source=GNW

It’s going to happen watch

I'd be happy with even half that amount.

$4.00 or $5.00 in 6 month to 1 year
Watch

Agreed with $APYP

Hard not to take notice of the move here - with excellent share structure now and actual product and sales. This is only going to get better and IMO getting through the last few year growing oaidbwas essential.
Let’s see how the next few weeks pans out here. My pre split shares just need to see .07-08 pps and I ended up green here in 5years. Lol.

I already green on my post split shares -just need this management to continue to execute.

I think we're gonna have a nice week. More people are talking about APYP.

$4.00 or $5.00 in 6 month to 1 year
Watch

On launch pad!

$APYP Form POS AM - Post-Effective amendments for registration statement

https://ih.advfn.com/stock-market/USOTC/appyea-qb-APYP/stock-news/93238717/form-pos-am-post-effective-amendments-for-regist

It'sa comin!!

Will see if they get stock
https://www.amazon.com/AppySleep-Wristband-Technology-Smartphone-Soluciones/dp/B0CTMNHQBX/ref=sr_1_2?crid=2TUQZ8FSK2S0A&keywords=appysleep&qid=1707413824&sprefix=appysleep%2Caps%2C139&sr=8-2

.

The Device I got from @SleepXclear $APYP is working on my sons Sleep Apnea!— Jack (@jwmario) January 31, 2024

Anybody here actually received the product yet AND tried it? Just wondering how functional it was and your review of it.

$4.00 or $5.00 in 6 month to 1 year
Watch

Agree!

Future dollar stock

Let’s go!

FDA says 561 deaths tied to recalled Philips sleep apnea machines. Sad news for sleep apnea machine users. Hopefully suffers of sleep apnea will find better options such as APYP. And hopefully APYP will fast track commercially with SleepX/ Appysleep to help those in need of a better option

Yes 1 good news and we’re going to run